Description
**CJC-1295 without DAC Research Overview**
—
**1. What it does**
CJC-1295 without DAC (also referred to as “Modified GRF 1-29”) is a synthetic analog of growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to increase natural growth hormone secretion, but without the Drug Affinity Complex (DAC) modification, it has a much shorter half-life compared to CJC-1295 with DAC. This makes it more pulsatile in action, closely mimicking the body’s natural release patterns of growth hormone.
—
**2. What are the main reported benefits**
– Increased natural growth hormone and IGF-1 production
– Enhanced muscle growth and fat loss
– Improved recovery from training and injuries
– Enhanced skin quality and elasticity
– Strengthened immune system
– Promotion of better sleep quality
—
**3. What are its normal applications**
– Research into growth hormone deficiency
– Studies on tissue regeneration and healing
– Athletic performance and recovery research
– Investigations into anti-aging therapies
—
**4. What are its common side effects**
Reported side effects include:
– Mild water retention
– Temporary tingling or numbness
– Injection site irritation
– Headaches
– Flushing (warm sensation)
Side effects are typically mild and transient.
—
**5. What is the recommended administration or dosage**
– **Typical Dosage**: 100 mcg to 300 mcg per injection
– **Administration Route**: Subcutaneous injection
**Timing:**
– Best administered 1 to 3 times per day, especially around workouts and before sleep, to mimic natural GH secretion pulses.
**Preparation:**
– CJC-1295 without DAC comes as a lyophilized powder and must be reconstituted with bacteriostatic water before use.
*Note:* It is often combined with GHRP-2, GHRP-6, or Ipamorelin for synergistic effects in research protocols.
—
